Michael Y.K. Leung
- Immunology top 2%
- Molecular Biology
- Oncology top 5%
- Infectious Diseases top 5%
- Cancer Research
- Co-authors
- Mercedes B. FuertesKatherine A. FitzgeraldRyan DugganGlen N. BarberThomas F. GajewskiSeng‐Ryong WooLeticia CorralesMaria-Luisa Alegre
- Topics
- interferon and immune responses (3 papers)Cancer Immunotherapy and Biomarkers (3 papers)SARS-CoV-2 and COVID-19 Research (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Michael Y.K. Leung
10 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Immunology 1.3k
- Molecular Biology 602
- Oncology 563
- Infectious Diseases 331
- Cancer Research 135
Countries citing papers authored by Michael Y.K. Leung
This map shows the geographic impact of Michael Y.K. Leung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Y.K. Leung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Y.K. Leung more than expected).
Fields of papers citing papers by Michael Y.K. Leung
This network shows the impact of papers produced by Michael Y.K. Leung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Y.K. Leung. The network helps show where Michael Y.K. Leung may publish in the future.
Co-authorship network of co-authors of Michael Y.K. Leung
This figure shows the co-authorship network connecting the top 25 collaborators of Michael Y.K. Leung. A scholar is included among the top collaborators of Michael Y.K. Leung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Y.K. Leung. Michael Y.K. Leung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Treatment with tocilizumab does not inhibit induction of anti-COVID-19 antibodies in patients with severe SARS-CoV-2 infection | 0 |
| 2 | 1 | |
| 3 | 24 | |
| 4 | STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumorsbreakdown → | 1413 |
| 5 | 72 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 86 | |
| 9 | 5 | |
| 10 | 8 | |
| 11 | 10 |
About Michael Y.K. Leung
Michael Y.K. Leung is a scholar working on Immunology, Biotechnology and Infectious Diseases, having authored 11 papers that have together received 1.6k indexed citations. Recurring topics across this work include interferon and immune responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Immunology (1.3k citations), Oncology (563 citations) and Infectious Diseases (331 citations). Michael Y.K. Leung has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Mercedes B. Fuertes, Katherine A. Fitzgerald, Ryan Duggan, Glen N. Barber, Thomas F. Gajewski, Seng‐Ryong Woo, Leticia Corrales, Maria-Luisa Alegre, Stefani Spranger and Ying Wang. Their work appears in journals such as Immunity, The Journal of Immunology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.